Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.
Press releases published on July 10, 2025
Dr. Irays Santamaria of Warshauer and Santamaria Discusses Dentures vs. Implants in HelloNation
EIN Presswire
·
July 10, 2025
Are dentures really more affordable than dental implants? BOSTON, MA, UNITED STATES, July 10, 2025 /EINPresswire.com/ -- Are dentures really more affordable than dental implants? Dr. Irays Santamaria of Warshauer and Santamaria addresses this widespread …
empatiX Consulting Welcomes New Class of eXplorers and Celebrates Graduates
EIN Presswire
·
July 10, 2025
Consultancy celebrates another milestone by watching young talent continue to grow BOSTON, MA, UNITED STATES, July 10, 2025 /EINPresswire.com/ -- EmpatiX Consulting has welcomed its newest team of eXplorer interns from Fairfield University, Clemson …
Melt-to-Make Showcases Patented Gummy Technology at IFT First Startup Pavilion
EIN Presswire
·
July 10, 2025
Patented pectin and sugar-free gummy base to take center stage as Melt-to-Make joins innovators at world-renowned food science event in Chicago NORTHAMPTON, MA, UNITED STATES, July 10, 2025 /EINPresswire.com/ -- Melt-to-Make™, an innovative B2B supplier …
UltraSight™ Appoints New Medical Advisory Board Members to Lead Clinical Plan for Machine Learning Cardiac Ultrasound
EIN Presswire
·
July 10, 2025
Three Leading Physicians Join Medical Advisory Board to Advance Clinical Strategy and Drive Adoption of Machine Learning Point‑of‑Care Cardiac Ultrasound BOSTON, MA, UNITED STATES, July 10, 2025 /EINPresswire.com/ -- UltraSight™, a digital health …
Africa Bitcoin Conference launches Diaspora Edition in Boston to unite Africans for financial freedom & innovation
EIN Presswire
·
July 10, 2025
ABCD is more than a conference; it’s a rallying call to the African diaspora whose remittances, investments …
Rapid7 to Report Second Quarter 2025 Financial Results on August 7
GlobeNewswire
·
July 10, 2025
BOSTON, July 10, 2025 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a leader in threat detection and exposure management, today announced that the company will release its second quarter 2025 financial results on Thursday, August 7, 2025, after the …
Cogent Biosciences Announces Closing of Upsized Public Offering of Shares of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
GlobeNewswire
·
July 10, 2025
WALTHAM, Mass. and BOULDER, Colo., July 10, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the closing of its previously …
MKS Named by Time as One of America’s Best Mid-Sized Companies
GlobeNewswire
·
July 10, 2025
ANDOVER, Mass., July 10, 2025 (GLOBE NEWSWIRE) -- MKS Inc. (NASDAQ: MKSI), (“MKS”), a global provider of enabling technologies that transform our world, was recognized today as one of America’s Best Mid-Sized Companies for 2025 by Time and Statista, Inc. “ …
Vor Bio Appoints Veteran Biotech Executive Sandy Mahatme as Chief Financial Officer and Chief Business Officer
GlobeNewswire
·
July 10, 2025
Mr. Mahatme brings decades of experience in strategic finance, capital formation, and operational leadership to support company’s transformation and growth in autoimmune disease CAMBRIDGE, Mass., July 10, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a …
CAR T-Cell Therapy Market to Surge at 40.2% CAGR Over the Next Five Years
GlobeNewswire
·
July 10, 2025
Boston, July 10, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Current R…
Boston Metal Announces $51 Million Convertible Note to Accelerate Scale-Up of Critical Metals Plant and Capitalize on Recent Steel Technology Milestone
GlobeNewswire
·
July 10, 2025
BOSTON, July 10, 2025 (GLOBE NEWSWIRE) -- Boston Metal, a technology company redefining global metals production, today announced it has raised $51 million in a convertible note investment from existing investors including BHP Ventures, Breakthrough Energy …
SiteWorx Announces New Product - The RCP Controlled Receptacle
GlobeNewswire
·
July 10, 2025
BOSTON , July 10, 2025 (GLOBE NEWSWIRE) -- SiteWorx Software USA, LLC today announced the new SWN-RCP, an advanced wireless receptacle designed to enhance energy efficiency in commercial spaces. This new plug load controller seamlessly integrates with the …
Byrna Technologies Reports Fiscal Second Quarter 2025 Results
GlobeNewswire
·
July 10, 2025
ANDOVER, Mass., July 10, 2025 (GLOBE NEWSWIRE) -- Byrna Technologies Inc. (“Byrna” or the “Company”) (Nasdaq: BYRN), a personal defense technology company specializing in the development, manufacture, and sale of innovative less-lethal personal security …
Stran & Company Appoints Veteran Financial Executive Brian M. Posner to its Board of Directors
GlobeNewswire
·
July 10, 2025
Quincy, MA, July 10, 2025 (GLOBE NEWSWIRE) -- Stran …
Acumen Pharmaceuticals to Present Studies on Cost Savings Associated with Use of pTau217 Screening Assay in Phase 2 ALTITUDE-AD Study and Sabirnetug Oligomer-Selectivity at the Alzheimer’s Association International Conference (AAIC®) 2025
GlobeNewswire
·
July 10, 2025
NEWTON, Mass., July 10, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s …
Diagonal Therapeutics Announces Publication of Data Characterizing the Healthcare System Cost and Impact of Hereditary Hemorrhagic Telangiectasia (HHT) in the American Journal of Hematology
GlobeNewswire
·
July 10, 2025
WATERTOWN, Mass., July 10, 2025 (GLOBE NEWSWIRE) -- Diagonal Therapeutics, a biotechnology company focused on correcting dysregulated signaling with clustering antibodies that address the underlying cause of intractable genetic diseases, today announced …
Biogen and Stoke Therapeutics Announce Presentation of Data from Studies of Zorevunersen, an Investigational Medicine for Dravet syndrome, at the 16th European Paediatric Neurology Society (EPNS) Congress
GlobeNewswire
·
July 10, 2025
– Data from an analysis designed to evaluate the potential effects of the Phase 3 zorevunersen dosing regimen showed improvements in cognition and behavior at Week 68 – – These findings support the inclusion of key secondary endpoints assessing cognition …
Rhythm Pharmaceuticals, Inc. Announces Pricing of Upsized Public Offering of Common Stock
GlobeNewswire
·
July 10, 2025
BOSTON, July 10, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) (“Rhythm”), a global, commercial-stage biopharmaceutical company dedicated to transforming the lives of patients living with rare neuroendocrine diseases, today announced …